DRUG
Bright Minds Biosciences Inc
52.00$
+7.8%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | +200.0% | +0.0% | +0.0% | 0.0% | +0.0% | 0.0% | +0.0% | – | – | – | – | +4.9% | +61.9% | +1.8% | -0.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -80.9% | +258.6% | +1,281.6% | +19.2% | +196.2% | +159.2% | -18.5% | +74.1% | -2.7% | -45.2% | +23.9% | -42.6% | -4.2% | -24.9% | +3.9% | +12.3% | -91.4% | +438.8% | -26.6% | +151.3% | +145.2% | +5.0% | +77.7% | +18.3% | +134.3% | -28.4% | – | |
| – | +141.4% | +11,014.2% | +357.9% | +129.4% | +16.8% | +79.4% | +44.7% | +9.6% | -29.3% | +12.8% | -31.9% | +112.4% | -26.3% | -38.5% | +23.1% | -13.7% | -0.3% | -11.8% | +7.9% | +33.7% | +27.5% | -18.7% | +26.0% | +63.9% | +114.8% | +1.3% | – | |
| – | -80.4% | +554.6% | +887.6% | +55.5% | +142.1% | +140.6% | -17.9% | +59.9% | -7.2% | -39.4% | +13.4% | -23.7% | -10.6% | -30.3% | +8.3% | +9.6% | -67.2% | -142.1% | – | +105.3% | +106.3% | -1.7% | +71.8% | +21.9% | +125.2% | -24.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -437.1% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | -99.5% | +11,322.0% | +88.2% | -25.3% | -94.7% | -17.3% | -21.5% | -28.4% | -41.6% | – | – | – | – | – | – | -14.9% | -25.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -436.4% | – | -6,047.2% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | -100.5% | – | – | -25.3% | -88.3% | -673.3% | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -436.4% | – | -6,047.2% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -7,511.4% | – | – | -404.2% | – | -4,780.2% | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.